Catalyst Crew Technologies Corp. (OTC: CCTC) announced today that it has submitted a corporate action request to the Financial Industry Regulatory Authority (FINRA) seeking approval for a proposed name change to LataMed AI Corp. and a corresponding change to the company's trading symbol. The move is intended to better reflect the company's strategic direction following its transition toward artificial intelligence-enabled healthcare technology, with an initial focus on Latin America.
The proposed corporate action, approved by the company's Board of Directors and majority shareholder, does not involve any reverse or forward stock split, recapitalization, change to authorized capital, or other modification to the capital structure. The issued and outstanding share count will remain unchanged, and shareholders will not need to take any action. Upon FINRA approval, the company plans to file a Certificate of Amendment with the Nevada Secretary of State to effect the name change, which would become effective after required filings and publication on FINRA's Daily List.
Dr. Kevin Rodan Levy, CEO of Catalyst Crew Technologies, stated that the name change is intended to align the company's public identity with its healthcare technology strategy and long-term market focus. The company is actively developing scalable digital health solutions for emerging markets, including telehealth infrastructure, remote patient monitoring, healthcare data analytics, and integrated digital care platforms.
The company noted that no assurance can be given that FINRA will approve the proposed name change or the requested trading symbol. For more information, visit https://catalystcrewai.com or review the company's filings with the U.S. Securities and Exchange Commission at www.sec.gov.
